Transcutaneous immunization with a novel lipid-based adjuvant protects against Chlamydia genital and respiratory infections

Vaccine

Volumn 27, Issue 44, 2009, Pages 6217-6225

  Hickey, Danica K ^a   Aldwell, Frank E ^b   Beagley, Kenneth W ^c  

^a UNIVERSITY OF NEWCASTLE   (Australia)

^b UNIVERSITY OF OTAGO   (New Zealand)

^c QUEENSLAND UNIVERSITY OF TECHNOLOGY   (Australia)

Author keywords

Adjuvant; Chlamydia; Lipid; Transcutaneous immunization

Indexed keywords

CHOLERA TOXIN; IMMUNOLOGICAL ADJUVANT; LINOLEIC ACID; LIPID; LIPID C; MYRISTIC ACID; OLEIC ACID; OLIGODEOXYNUCLEOTIDE; OUTER MEMBRANE PROTEIN; PALMITIC ACID; RECOMBINANT OUTER MEMBRANE PROTEIN; STEARIC ACID; UNCLASSIFIED DRUG;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANTIBODY RESPONSE; ARTICLE; CELLULAR IMMUNITY; CHLAMYDIA; CHLAMYDIASIS; CONTROLLED STUDY; FEMALE; GENITAL TRACT INFECTION; IMMUNIZATION; INFECTION PREVENTION; MOUSE; NONHUMAN; PRIORITY JOURNAL; RESPIRATORY TRACT INFECTION;

ADJUVANTS, IMMUNOLOGIC; ADMINISTRATION, CUTANEOUS; ANIMALS; ANTIBODIES, BACTERIAL; BACTERIAL VACCINES; CHLAMYDIA INFECTIONS; CHLAMYDIA MURIDARUM; FEMALE; GENITAL DISEASES, FEMALE; IMMUNITY, MUCOSAL; IMMUNOGLOBULIN A; IMMUNOGLOBULIN G; MICE; MICE, INBRED BALB C; PORINS; RESPIRATORY TRACT INFECTIONS; T-LYMPHOCYTES; TRIGLYCERIDES; VAGINA;

EID: 70349973696     PISSN: 0264410X     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.vaccine.2009.08.001     Document Type: Article

References (57)

1. Washington A.E., and Katz P. Cost of and payment source for pelvic inflammatory disease. Trends and projections, 1983 through 2000. JAMA (1991) 2565-2569
2. Schachter J., Stoner E., and Moncada J. Screening for chlamydial infections in women attending family planning clinics. West J Med (1983) 375-379
3. Stamm W.E., and Cole B. Asymptomatic Chlamydia trachomatis urethritis in men. Sex Transm Dis (1986) 163-165
4. Hansbro P.M., Beagley K.W., Horvat J.C., and Gibson P.G. Role of atypical bacterial infection of the lung in predisposition/protection of asthma. Pharmacol Ther 101 March (3) (2004) 193-210
5. Horvat J., Beagley K., Wade M., Preston J., Hansbro N., Hickey D., et al. Neonatal chlamydial infection induces mixed T cell responses that drive allergic airways disease. Am J Respir Crit Care Med June (2007)
6. Campbell L.A., and Kuo C.C. Chlamydia pneumoniae-an infectious risk factor for atherosclerosis?. Nat Rev Microbiol 2 1 (2004) 23-32
7. Henry C., Hudson A., Gérard H., Franco P., and Wolford L. Identification of Chlamydia trachomatis in the human temporomandibular joint. J Oral Maxillofac Surg 57 June (6) (1999) 683-688 [discussion 9]
8. Balin B., Gérard H., Arking E., Appelt D., Branigan P., Abrams J., et al. Identification and localization of Chlamydia pneumoniae in the Alzheimer's brain. Med Microbiol Immunol 187 June (1) (1998) 23-42
9. Somani J., Bhullar V., Workowski K., Farshy C., and Black C. Multiple drug-resistant Chlamydia trachomatis associated with clinical treatment failure. J Infect Dis 181 April (4) (2000) 1421-1427
10. Brunham R.C., Pourbohloul B., Mak S., White R., and Rekart M.L. The unexpected impact of a Chlamydia trachomatis infection control program on susceptibility to reinfection. J Infect Dis 192 November (10) (2005) 1836-1844
11. Grayston J.T., Wang S.P., Yeh L.J., and Kuo C.C. Importance of reinfection in the pathogenesis of trachoma. Rev Infect Dis 7 January (6) (1985) 717-725
12. Caldwell H.D., and Schachter J. Antigenic analysis of the major outer membrane protein of Chlamydia spp. Infect Immun (1982) 1024-1031
13. Brunham R.C., and Peeling R.W. Chlamydia trachomatis antigens: role in immunity and pathogenesis. Infect Agent Dis (1994) 218-233
14. Agrawal T., Vats V., Salhan S., and Mittal A. Mucosal and peripheral immune responses to chlamydial heat shock proteins in women infected with Chlamydia trachomatis. Clin Exp Immunol 148 June (3) (2007) 461-468
15. Barker C.J., Beagley K.W., Hafner L.M., and Timms P. In silico identification and in vivo analysis of a novel T-cell antigen from Chlamydia, NrdB. Vaccine 26 March (10) (2008) 1285-1296
16. Crane D.D., Carlson J.H., Fischer E.R., Bavoil P., Hsia R.C., Tan C., et al. Chlamydia trachomatis polymorphic membrane protein D is a species-common pan-neutralizing antigen. Proc Natl Acad Sci USA 103 February (6) (2006) 1894-1899
17. McNeilly C.L., Beagley K.W., Moore R.J., Haring V., Timms P., and Hafner L.M. Expression library immunization confers partial protection against Chlamydia muridarum genital infection. Vaccine 25 March (14) (2007) 2643-2655
18. Murthy A.K., Chambers J.P., Meier P.A., Zhong G., and Arulanandam B.P. Intranasal vaccination with a secreted chlamydial protein enhances resolution of genital Chlamydia muridarum infection, protects against oviduct pathology, and is highly dependent upon endogenous gamma interferon production. Infect Immun 75 2 (2007) 666-676
19. van Ginkel F., Jackson R., Yuki Y., and McGhee J. Cutting edge: the mucosal adjuvant cholera toxin redirects vaccine proteins into olfactory tissues. J Immunol 165 November (9) (2000) 4778-4782
20. Mutsch M., Zhou W., Rhodes P., Bopp M., Chen R.T., Linder T., et al. Use of the inactivated intranasal influenza vaccine and the risk of Bell's palsy in Switzerland. N Engl J Med 350 February (9) (2004) 896-903
21. Frech S.A., Dupont H.L., Bourgeois A.L., McKenzie R., Belkind-Gerson J., Figueroa J.F., et al. Use of a patch containing heat-labile toxin from Escherichia coli against travellers' diarrhoea: a phase II, randomised, double-blind, placebo-controlled field trial. Lancet 371 June (9629) (2008) 2019-2025
22. Aldwell F.E., Tucker I.G., de Lisle G.W., and Buddle B.M. Oral delivery of Mycobacterium bovis BCG in a lipid formulation induces resistance to pulmonary tuberculosis in mice. Infect Immun 71 January (1) (2003) 101-108
23. Buddle B., Aldwell F., Skinner M., de Lisle G., Denis M., Vordermeier H., et al. Effect of oral vaccination of cattle with lipid-formulated BCG on immune responses and protection against bovine tuberculosis. Vaccine 23 May (27) (2005) 3581-3589
24. Aldwell F., Keen D., Parlane N., Skinner M., de Lisle G., and Buddle B. Oral vaccination with Mycobacterium bovis BCG in a lipid formulation induces resistance to pulmonary tuberculosis in brushtail possums. Vaccine 22 December (1) (2003) 70-76
25. Aldwell F.E., Cross M.L., Fitzpatrick C.E., Lambeth M.R., de Lisle G.W., and Buddle B.M. Oral delivery of lipid-encapsulated Mycobacterium bovis BCG extends survival of the bacillus in vivo and induces a long-term protective immune response against tuberculosis. Vaccine 24 March (12) (2006) 2071-2078
26. Glenn G.M., Rao M., Matyas G.R., and Alving C.R. Skin immunization made possible by cholera toxin [letter]. Nature 391 6670 (1998) 851
27. Steinman R.M. The dendritic cell system and its role in immunogenicity. Annu Rev Immunol 9 (1991) 271-296
28. Banchereau J., and Steinman R.M. Dendritic cells and the control of immunity. Nature 392 March (6673) (1998) 245-252
29. Berry L.J., Hickey D.K., Skelding K.A., Bao S., Rendina A.M., Hansbro P.M., et al. Transcutaneous immunization with combined cholera toxin and CpG adjuvant protects against Chlamydia muridarum genital tract infection. Infect Immun 72 February (2) (2004) 1019-1028
30. Skelding K.A., Hickey D.K., Horvat J.C., Bao S., Roberts K.G., Finnie J.M., et al. Comparison of intranasal and transcutaneous immunization for induction of protective immunity against Chlamydia muridarum respiratory tract infection. Vaccine 24 January (3) (2006) 355-366
31. Gockel C.M., Bao S., and Beagley K.W. Transcutaneous immunization induces mucosal and systemic immunity: a potent method for targeting immunity to the female reproductive tract. Mol Immunol 37 June (9) (2000) 537-544
32. Su H., Raymond L., Rockey D.D., Fischer E., Hackstadt T., and Caldwell H.D. A recombinant Chlamydia trachomatis major outer membrane protein binds to heparan sulfate receptors on epithelial cells. Proc Natl Acad Sci USA 93 October (20) (1996) 11143-11148
33. Hickey D.K., Jones R.C., Bao S., Blake A.E., Skelding K.A., Berry L.J., et al. Intranasal immunization with C. muridarum major outer membrane protein (MOMP) and cholera toxin elicits local production of neutralising IgA in the prostate. Vaccine 22 October (31-32) (2004) 4306-4315
34. Yang X., HayGlass K.T., and Brunham R.C. Genetically determined differences in IL-10 and IFN-gamma responses correlate with clearance of Chlamydia trachomatis mouse pneumonitis infection. J Immunol 156 June (11) (1996) 4338-4344
35. Yang X. Role of cytokines in Chlamydia trachomatis protective immunity and immunopathology. Curr Pharm Des 9 1 (2003) 67-73
36. Johansson M., Ward M., and Lycke N. B-cell-deficient mice develop complete immune protection against genital tract infection with Chlamydia trachomatis. Immunology (1997) 422-428
37. Morrison S.G., and Morrison R.P. Resolution of secondary Chlamydia trachomatis genital tract infection in immune mice with depletion of both CD4+ and CD8+ T cells. Infect Immun (2001) 2643-2649
38. Morrison S.G., and Morrison R.P. A predominant role for antibody in acquired immunity to chlamydial genital tract reinfection. J Immunol (2005) 7536-7542
39. Morrison S.G., Su H., Caldwell H.D., and Morrison R.P. Immunity to murine Chlamydia trachomatis genital tract reinfection involves B cells and CD4(+) T cells but not CD8(+) T cells. Infect Immun (2000) 6979-6987
40. Caldwell H.D., and Perry L.J. Neutralization of Chlamydia trachomatis infectivity with antibodies to the major outer membrane protein. Infect Immun (1982) 745-754
41. Pal S., Theodor I., Peterson E.M., and de la Maza L.M. Monoclonal immunoglobulin A antibody to the major outer membrane protein of the Chlamydia trachomatis mouse pneumonitis biovar protects mice against a chlamydial genital challenge. Vaccine (1997) 575-582
42. Yoshida M., Kobayashi K., Kuo T., Bry L., Glickman J., Claypool S., et al. Neonatal Fc receptor for IgG regulates mucosal immune responses to luminal bacteria. J Clin Invest 116 August (8) (2006) 2142-2151
43. Yoshida M., Masuda A., Kuo T., Kobayashi K., Claypool S., Takagawa T., et al. IgG transport across mucosal barriers by neonatal Fc receptor for IgG and mucosal immunity. Springer Semin Immunopathol 28 December (4) (2006) 397-403
44. Kutteh W.H., and Mestecky J. Secretory immunity in the female reproductive tract. Am J Reprod Immunol (1994) 40-46
45. Kutteh W.H., Hatch K.D., Blackwell R.E., and Mestecky J. Secretory immune system of the female reproductive tract: I. Immunoglobulin and secretory component-containing cells. Obstet Gynecol (1988) 56-60
46. Orlandi P.A., and Fishman P.H. Filipin-dependent inhibition of cholera toxin: evidence for toxin internalization and activation through caveolae-like domains. J Cell Biol (1998) 905-915
47. Wolf A.A., Jobling M.G., Wimer-Mackin S., Ferguson-Maltzman M., Madara J.L., Holmes R.K., et al. Ganglioside structure dictates signal transduction by cholera toxin and association with caveolae-like membrane domains in polarized epithelia. J Cell Biol (1998) 917-927
48. Wolf A.A., Fujinaga Y., and Lencer W.I. Uncoupling of the cholera toxin-G(M1) ganglioside receptor complex from endocytosis, retrograde Golgi trafficking, and downstream signal transduction by depletion of membrane cholesterol. J Biol Chem (2002) 16249-16256
49. Fujinaga Y., Wolf A.A., Rodighiero C., and Wheeler H. Gangliosides that associate with lipid rafts mediate transport of cholera and related toxins from the plasma membrane to endoplasmic reticulm. Mol Biol Cell (2003)
50. Amer A.O., Byrne B.G., and Swanson M.S. Macrophages rapidly transfer pathogens from lipid raft vacuoles to autophagosomes. Autophagy (2005)
51. Latz E., Schoenemeyer A., Visintin A., Fitzgerald K.A., Monks B.G., Knetter C.F., et al. TLR9 signals after translocating from the ER to CpG DNA in the lysosome. Nat Immunol (2004) 190-198
52. Klausner R.D., Kleinfeld A.M., Hoover R.L., and Karnovsky M.J. Lipid domains in membranes. Evidence derived from structural perturbations induced by free fatty acids and lifetime heterogeneity analysis. J Biol Chem (1980) 1286-1295
53. Simons K., and Vaz W.L. Model systems, lipid rafts, and cell membranes. Annu Rev Biophys Biomol Struct (2004) 269-295
54. Dykstra M., Cherukuri A., Sohn H.W., Tzeng S.J., and Pierce S.K. Location is everything: lipid rafts and immune cell signalling. Annu Rev Immunol (2003) 457-481
55. Stulnig T.M., Berger M., Sigmund T., Raederstorff D., Stockinger H., and Waldhausl W. Polyunsaturated fatty acids inhibit T cell signal transduction by modification of detergent-insoluble membrane domains. J Cell Biol 143 November (3) (1998) 637-644
56. Stulnig T.M., Huber J., Leitinger N., Imre E.M., Angelisova P., Nowotny P., et al. Polyunsaturated eicosapentaenoic acid displaces proteins from membrane rafts by altering raft lipid composition. J Biol Chem (2001) 37335-37340
57. Weatherill A.R., Lee J.Y., Zhao L., Lemay D.G., Youn H.S., and Hwang D.H. Saturated and polyunsaturated fatty acids reciprocally modulate dendritic cell functions mediated through TLR4. J Immunol 174 May (9) (2005) 5390-5397